PRICE T ROWE ASSOCIATES INC /MD/ - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$38,187
-63.9%
2,364,459
-7.1%
0.01%
-60.0%
Q2 2023$105,638
-33.9%
2,545,465
-4.2%
0.02%
-37.5%
Q1 2023$159,714
+0.4%
2,655,686
+22.5%
0.02%
-7.7%
Q4 2022$159,054
-99.9%
2,168,431
-8.6%
0.03%
-13.3%
Q3 2022$180,225,000
+11.2%
2,371,986
+1.7%
0.03%
+50.0%
Q2 2022$162,030,000
-7.5%
2,331,367
+10.3%
0.02%
+11.1%
Q1 2022$175,075,000
+56.9%
2,113,151
+42.2%
0.02%
+80.0%
Q4 2021$111,581,000
-32.9%
1,486,168
+3.7%
0.01%
-37.5%
Q3 2021$166,410,000
-52.2%
1,432,467
-8.7%
0.02%
-50.0%
Q2 2021$348,143,000
+114.5%
1,569,485
+27.8%
0.03%
+100.0%
Q1 2021$162,278,000
-24.3%
1,227,702
-0.8%
0.02%
-27.3%
Q4 2020$214,259,000
+58.4%
1,238,204
+1.9%
0.02%
+37.5%
Q3 2020$135,277,000
+93.1%
1,215,318
+2.9%
0.02%
+77.8%
Q2 2020$70,049,000
-16.8%
1,181,267
-5.6%
0.01%
-30.8%
Q1 2020$84,243,000
-24.9%
1,251,011
-6.0%
0.01%
-13.3%
Q4 2019$112,133,000
-5.6%
1,330,637
-16.2%
0.02%
-11.8%
Q3 2019$118,738,000
-20.3%
1,587,837
-32.6%
0.02%
-19.0%
Q2 2019$149,064,000
+59.8%
2,357,482
+21.8%
0.02%
+50.0%
Q1 2019$93,269,000
+44.6%
1,936,247
+0.5%
0.01%
+27.3%
Q4 2018$64,502,000
-40.1%
1,926,579
-6.3%
0.01%
-31.2%
Q3 2018$107,689,000
+404.8%
2,055,136
+201.6%
0.02%
+433.3%
Q2 2018$21,332,000
-29.2%
681,519
-73.6%
0.00%
-50.0%
Q2 2016$30,116,000
-19.6%
2,580,593
-0.3%
0.01%
-25.0%
Q1 2016$37,481,000
-32.7%
2,588,465
-0.0%
0.01%
-33.3%
Q4 2015$55,730,0002,588,8250.01%
Other shareholders
NOVOCURE LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders